Tirzepatide, a recently approved medication, is generating significant interest in the healthcare community as a potential treatment for both diabetes, type 2 and reducing body fat. This groundbreaking drug works by stimulating two distinct receptors, GLP-1 and GIP, leading to better glucose control and substantial weight reduction in clinical tria